CNE100001BC7
CNE100001BC7
HAISCO PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 69.62B EUR | 74.3B EUR | 60.79B EUR |
Enterprise Value | 69.27B EUR | 74.71B EUR | 61.22B EUR |
Valuation Multiples | |||
Trailing P/E | 70.14x | 82.76x | 93.85x |
Forward P/E | 44.18x | -- | -- |
Price to Sales | 12.7x | 14.04x | 13.07x |
Price to Book | 14.32x | 15.43x | 12.55x |
EV/Revenue | 12.63x | 14.12x | 13.16x |
EV/EBITDA | 61.57x | 74.62x | 82.71x |
Price to FCF (P/FCF) | 103.37x | 63.33x | 79.28x |
EV/FCF | 102.85x | 63.68x | 79.84x |
FCF Yield | 0.97% | 1.58% | 1.26% |